Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an <i>ACVRL1</i> ( <i>ALK1</i> ) Mutation

7 Jan 2010

Abstract excerpt

RATIONALE: Activin A receptor type II-like kinase-1 (ACVRL1, also known as ALK1) mutation is a cause of hereditary hemorrhagic telangiectasia (HHT) and/or heritable pulmonary arterial hypertension (PAH). OBJECTIVES: To describe the characteristics of patients with PAH carrying an ACVRL1 mutation. METHODS: We reviewed clinical, functional, and hemodynamic characteristics of 32 patients with PAH carrying an ACVRL1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Pulmonary Hypertension Research and Treatments
Share to Vascular Anomalies and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20056902
DOI: 10.1164/rccm.200908-1284oc

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an <i>ACVRL1</i> ( <i>ALK1</i> ) MutationPMID 20056902Read ↗

Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene.Semantic proximity Read ↗

Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.Semantic proximity Read ↗

Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

ACVRL1 variation-induced hereditary hemorrhagic telangiectasia presenting with pulmonary arterial hypertension: clinical and genetic analyses of three case studies.Semantic proximity Read ↗

Genetics and genomics of pulmonary arterial hypertension.Semantic proximity Read ↗

Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.Semantic proximity Read ↗

Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.Semantic proximity Read ↗

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.Semantic proximity Read ↗

BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasiaSemantic proximity Read ↗

Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.Semantic proximity Read ↗

Identification of multiple ACVRL1 mutations in patients with pulmonary arterial hypertension by targeted exome capture.Semantic proximity Read ↗

Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.